Health status and hypertension: A population-based study

Journal of Clinical Epidemiology

Volumn 49, Issue 11, 1996, Pages 1239-1245

  Lawrence, William F ^a,b   Fryback, Dennis G ^a   Martin, Patricia A ^a   Klein, Ronald ^a   Klein, Barbara E K ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Antihypertensive agents; Cross sectional study; Health status; Hypertension; Population study; Quality of life (health related)

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; WELLBEING;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; WISCONSIN;

EID: 0030298468     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(96)00220-X     Document Type: Article

References (34)

1. 1. Hoerr SO, Hoerr's law. Am J Surg 1962; 103: 411.
2. 2. Haynes RB, Sacken DL, Taylor W, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labelling of hypertensive patients. N Engl J Med 1978; 299: 741-744.
3. 3. Wagner EH, Strogatz DS. Hypertension labeling and well-being: Alternative explanations in cross-sectional data. J Chron Dis 1984; 12: 943-947.
4. 4. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993; 152: 154-183.
5. 5. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314: 1357-1364.
6. 6. Croog SH, Kong W, Levine S, Weir MR, et al. Hypertensive black men and women: Quality of life and effects of antihypertensive medications. Arch Intern Med 1990; 150: 1733-1741.
7. 7. Applegate WB, Phillips HL, Schnaper H, et al. A randomized controlled trial of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med 1991; 151: 1817-1823.
8. 8. Testa MA, Hollenberg NK, Anderson RB, Williams GH. Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system. Am J Hypertens 1991; 4: 363-373.
9. 9. Testa MA, Anderson RB, Nackley JF, et al. Quality of life and antihypertensive therapy in men: A comparison of captopril with enalapril. N Engl J Med 1993; 328: 907-913.
10. 10. Goldstein G, Materson BJ, Cushman WC, Reda DJ, Freis ED, Ramirez EA, et al. Treatment of hypertension in the elderly. II. Cognitive and behavioral function: Results of a Veterans Affairs Cooperative Study. Hypertension 1990; 15: 1413-1423.
11. 11. Wassertheil-Smoller S, Blaufox D, Oberman A, et al. Effect of antihypertensives on sexual function and quality of life: The TAIM Study. Ann Intern Med 1991; 114: 613-620.
12. 12. The Treatment of Mild Hypertension Research Group. The Treatment of Mild Hypertension Study: A randomized, placebo controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med 1991; 151: 1413-1423.
13. 13. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of Mild Hypertension Study: Final results. JAMA 1993; 270: 713-724.
14. 14. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: Results from the Medical Outcomes Study. JAMA 1989; 262: 907-913.
15. 15. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: Initial catalog of health state quality factors. Med Decis Making 1993; 13: 89-102.
16. 16. Klein R, Klein BEK, Linton KLP, deMets DL. The Beaver Dam Eye Study: Visual acuity. Ophthalmology 1991; 98: 1310-1315.
17. 17. Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
18. 18. Kaplan RM, Anderson JP. A general policy model: Update and applications. Health Services Res 1988; 23: 203-235.
19. 19. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programs. Health Services Res 1972; 7: 118-133.
20. 20. Froberg DG, Kane RL. Methodology for measurement of health-state preferences. II. Scaling methods. J Clin Epidemiol 1989; 42: 459-471.
21. 21. Patrick DL, Erickson P. Health Status and Health Policy. New York: Oxford University Press; 1993.
22. 22. Ware JE. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center; 1993.
23. 23. Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chron Dis 1978; 31: 697-704.
24. 24. Nease RF, Kneeland T, O'Connor GT, et al. Variation in patient utilities for outcomes of the management of chronic stable angina. JAMA 1995; 273: 1185-1190.
25. 25. Ware JE, Nelson EC, Sherbourne CD, Stewart AL. Preliminary tests of a 6-item general health survey: A patient application. In: Stewart AL, Ware JE, Eds. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, North Carolina: Duke University Press; 1992.
26. 26. Kaplan RM, Anderson JP. A general health policy model: Update and applications. Health Serv Res 1988; 23: 203-235.
27. 27. U.S. Congress, Office of Technology Assessment. Evaluation of the Oregon Medicaid Proposal. OTA-H-531. Washington, D.C.: U.S. Government Printing Office; 1992.
28. 28. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons; 1989.
29. 29. Wagner EH, James SA, Beresford SAA, et al. The Edgecombe County High Blood Pressure Control Program. I. Correlates of uncontrolled hypertension at baseline. Am J Public Health 1984; 74: 737-742.
30. 30. Siscovick DS, Strogatz DS, Fletcher SW, Leake B, Brook RH. The asso ciation between hypertension treatment, control, and functional status. J Gen Intern Med 1987; 2: 406-410.
31. 31. Battelle Medical Technology Assessment and Policy Research Center. Health Utility and Health Status Outcomes of Antihypertensive Treatment. Washington, D.C.: Battelle; 1992.
32. 32. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-838.
33. 33. Tsevat J, Weinstein MC, Williams LW, Tosteson ANA, Goldman L. Expected gains in life expectancy form various coronary heart disease risk factor modifications. Circulation 1991; 83: 1194-1201.
34. 34. Jachuck SJ, Brierly H, Jachuck S, Willcox PM. The effect of hypotensive drugs on the quality of life. J R Coll Gen Pract 1982; 32: 103-105.